198 related articles for article (PubMed ID: 9061347)
21. The IDENTIFY study: the investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer - a multicentre observational study.
Khadhouri S; Gallagher KM; MacKenzie KR; Shah TT; Gao C; Moore S; Zimmermann EF; Edison E; Jefferies M; Nambiar A; Mannas MP; Lee T; Marra G; Lillaz B; Gómez Rivas J; Olivier J; Assmus MA; Uçar T; Claps F; Boltri M; Burnhope T; Nkwam N; Tanasescu G; Boxall NE; Downey AP; Lal AA; Antón-Juanilla M; Clarke H; Lau DHW; Gillams K; Crockett M; Nielsen M; Takwoingi Y; Chuchu N; O'Rourke J; MacLennan G; McGrath JS; Kasivisvanathan V;
BJU Int; 2021 Oct; 128(4):440-450. PubMed ID: 33991045
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of haematuria referrals: two-year data from a single large university hospital in Denmark.
Elmussareh M; Young M; Ordell Sundelin M; Bak-Ipsen CB; Graumann O; Jensen JB
Scand J Urol; 2017 Aug; 51(4):282-289. PubMed ID: 28406341
[TBL] [Abstract][Full Text] [Related]
23. Do patients with frank haematuria referred under the two-week rule have a higher incidence of bladder cancer?
Thiruchelvam N; Mostafid H
Ann R Coll Surg Engl; 2005 Sep; 87(5):345-7. PubMed ID: 16176693
[TBL] [Abstract][Full Text] [Related]
24. Developing a Diagnostic Multivariable Prediction Model for Urinary Tract Cancer in Patients Referred with Haematuria: Results from the IDENTIFY Collaborative Study.
Khadhouri S; Gallagher KM; MacKenzie KR; Shah TT; Gao C; Moore S; Zimmermann EF; Edison E; Jefferies M; Nambiar A; Anbarasan T; Mannas MP; Lee T; Marra G; Gómez Rivas J; Marcq G; Assmus MA; Uçar T; Claps F; Boltri M; La Montagna G; Burnhope T; Nkwam N; Austin T; Boxall NE; Downey AP; Sukhu TA; Antón-Juanilla M; Rai S; Chin YF; Moore M; Drake T; Green JSA; Goulao B; MacLennan G; Nielsen M; McGrath JS; Kasivisvanathan V;
Eur Urol Focus; 2022 Nov; 8(6):1673-1682. PubMed ID: 35760722
[TBL] [Abstract][Full Text] [Related]
25. 'One stop' haematuria clinic in Fremantle Hospital, Western Australia: a report of the first 500 patients.
Ooi WL; Lee F; Wallace DM; Hayne D
BJU Int; 2011 Nov; 108 Suppl 2():62-6. PubMed ID: 22085132
[TBL] [Abstract][Full Text] [Related]
26. The '2-week wait' rule for referrals for suspected urological cancers--urgent need for refinement of criteria.
Hawary AM; Warburton HE; Brough RJ; Collins GN; Brown SC; O'Reilly PH; Adeyoju AA
Ann R Coll Surg Engl; 2008 Sep; 90(6):517-22. PubMed ID: 18765032
[TBL] [Abstract][Full Text] [Related]
27. Non-visible haematuria: would discontinuing urgent investigation have a visible impact?
John JB; Coscione A; Acher P; Speakman M
Br J Hosp Med (Lond); 2020 Apr; 81(4):1-7. PubMed ID: 32339006
[TBL] [Abstract][Full Text] [Related]
28. Factors affecting the timeliness and adequacy of haematuria assessment in bladder cancer: a systematic review.
Ngo B; Perera M; Papa N; Bolton D; Sengupta S
BJU Int; 2017 May; 119 Suppl 5():10-18. PubMed ID: 28544294
[TBL] [Abstract][Full Text] [Related]
29. Undiagnosed macroscopic haematuria revisited: a follow-up of 146 patients.
Sells H; Cox R
BJU Int; 2001 Jul; 88(1):6-8. PubMed ID: 11446836
[TBL] [Abstract][Full Text] [Related]
30. Microscopic haematuria: urological investigation using a standard protocol.
Sultana SR; Goodman CM; Byrne DJ; Baxby K
Br J Urol; 1996 Nov; 78(5):691-6; discussion 697-8. PubMed ID: 8976762
[TBL] [Abstract][Full Text] [Related]
31. Microscopic Hematuria as a Screening Tool for Urologic Malignancies in Women.
Jeppson PC; Jakus-Waldman S; Yazdany T; Schimpf MO; Ferzandi TR; Yurteri-Kaplan LA; Knoepp L; Mamik M; Resnick HE; Ward RM;
Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):9-15. PubMed ID: 30998541
[TBL] [Abstract][Full Text] [Related]
32. Immunocytology in the assessment of patients with painless gross haematuria.
Schmitz-Dräger B; Tirsar LA; Schmitz-Dräger C; Dörsam J; Bismarck E; Ebert T
BJU Int; 2008 Feb; 101(4):455-8. PubMed ID: 18005211
[TBL] [Abstract][Full Text] [Related]
33. Assessment and management of haematuria in the general practice setting.
O'Connor E; McVey A; Demkiw S; Lawrentschuk N; Murphy DG
Aust J Gen Pract; 2021 Jul; 50(7):467-471. PubMed ID: 34189542
[TBL] [Abstract][Full Text] [Related]
34. Risk of genitourinary malignancy in patients that receive anticoagulant or antiplatelet therapy.
Rysankova K; Vrtkova A; Viktoria MG; Vesela A; Krhut J
Bratisl Lek Listy; 2023; 124(10):738-741. PubMed ID: 37789788
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of prostate cancer in men with haematuria: a systematic review and meta-analysis.
Hansen RS; Biørn SH; Birk-Korch JB; Sheikh SP; Poulsen MH; Vinholt PJ
BJU Int; 2023 May; 131(5):530-539. PubMed ID: 36522728
[TBL] [Abstract][Full Text] [Related]
36. Predictors of delay to cystoscopy and adequacy of investigations in patients with haematuria.
Ngo B; Papa N; Perera M; Bolton D; Sengupta S
BJU Int; 2017 May; 119 Suppl 5():19-25. PubMed ID: 28544302
[TBL] [Abstract][Full Text] [Related]
37. [Low-grade renal trauma (part I): diagnostic validity of haematuria].
Grill R; Masková V; Ryantová V; Urban M
Acta Chir Orthop Traumatol Cech; 2010 Feb; 77(1):43-5. PubMed ID: 20214860
[TBL] [Abstract][Full Text] [Related]
38. The value of urinary red cell shape in the diagnosis of glomerular and post-glomerular haematuria. A meta-analysis.
Offringa M; Benbassat J
Postgrad Med J; 1992 Aug; 68(802):648-54. PubMed ID: 1448406
[TBL] [Abstract][Full Text] [Related]
39. The results of routine evaluation of adult patients with haematuria analysed according to referral form information with 2-year follow-up.
Boman H; Hedelin H; Holmäng S
Scand J Urol Nephrol; 2001 Dec; 35(6):497-501. PubMed ID: 11848430
[TBL] [Abstract][Full Text] [Related]
40. The haematuria clinic--referral patterns in Northern Ireland.
Ho ET; Johnston SR; Keane PF
Ulster Med J; 1998 May; 67(1):25-8. PubMed ID: 9652195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
